6Yura Y, Mandai M, Konishi I, et al. Loss of Fhit protein expres- sion in High grade and advanced stage endometrial carcinomas[J]. AnticancerRes, 2003,23(3 C):2837 - 2843.
7Hadaczek P, Gronwald J, Chosia M, et al. Fhit protein expression in endometrial cancers:no correlation with histological grade[J]. Pol JPathol,2001,52(4): 199- 203.
8Orbo A, Kaino T, Ames M, et a l. Geneticderangementsin the tumor suppressorgene PTEN in endometrial precancer sasprongostic markers for cancer development:apopulation.based study from northern Norway with long-term followup[J]. GynecolOncol, 2004,95:82- 88.
10Athanassiadou P, Athanassiades P, Grapsa D, et al. The prognostic value of PTEN,p53,and beta-catenin in endometrial carcinoma:a prospective immunocytochemical siudy[J]. Int J Gynecol Cancer, 2007,17(3) : 697 - 704.
二级参考文献13
1[1]Porter PL, Malone KE, Heagerty PJ, et al. Expression of cell-cycle regulators P27kip1 and cyclin E, alone and in combination, correlate with survial in young breast cancer patients. Nat Med, 1997,3(2):220-225.
2[2]Xiangming C, Natsugoe S, Takao S, et al.The cooperative role of P27 with cyclin E in the prognosis of advanced gastric carcinoma.Cancer, 2000, 89(6):1214-1219.
3[3]Polyak K, Lee MH, Erdjument-Beomage H, et al. Clone of P27kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell, 1994, 78(1):59-66.
4[4]Bamberger AM, Riethdorf L, Milde-Langosch K, et al. Strongly reduced expression of the cell cycle inhibitor P27 in endometrial neoplasia. Virchows Arch, 1999, 434(5):423-428.
5[5]Singh SP, Lipman J, Goldman J, et al. Loss or altered subceller localization of P27 in barrett's associated adenocarcinoma. Cancer Res, 1998,58(8):1730-1735.
6[6]Georgieva J, Sinha P, schadendorf D. Expression of cyclins and cyclin dependent kinases in human benign and malignant melanocytic lesions. Clin Pathol, 2001,54(3):229-235.
7[7]Ito K,Sasano H,Yoshida Y, et al. Immunohistochemical study of cyclins D and E and cyclin dependent kinase (cdk) 2 and 4 in human endometrial carcinoma. Anticancer research, 1998,18(3A):1661-1664.
